AbbVie Inc. (ETR:4AB)
Germany · Delayed Price · Currency is EUR 201.50
+0.50 (0.25%)
Oct 10, 2025, 5:35 PM CET
AbbVie Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
Net Income | 3,771 | 4,286 | 4,873 | 11,845 | 11,549 | 4,622 | Upgrade |
Depreciation & Amortization | 8,270 | 8,386 | 8,698 | 8,467 | 8,521 | 6,471 | Upgrade |
Stock-Based Compensation | 934 | 911 | 747 | 671 | 692 | 753 | Upgrade |
Other Adjustments | 4,621 | 8,005 | 5,708 | 4,054 | 3,246 | 5,636 | Upgrade |
Change in Receivables | -765 | 207 | 66 | -1,455 | -1,321 | -929 | Upgrade |
Changes in Inventories | -403 | -319 | -417 | -686 | -142 | -40 | Upgrade |
Changes in Income Taxes Payable | -2,749 | -3,208 | -488 | 542 | -1,290 | -573 | Upgrade |
Changes in Other Operating Activities | 1,128 | 538 | 3,652 | 1,505 | 1,522 | 1,648 | Upgrade |
Operating Cash Flow | 19,283 | 18,806 | 22,839 | 24,943 | 22,777 | 17,588 | Upgrade |
Operating Cash Flow Growth | 3.46% | -17.66% | -8.43% | 9.51% | 29.50% | 32.00% | Upgrade |
Capital Expenditures | -1,044 | -974 | -777 | -695 | -787 | -798 | Upgrade |
Purchases of Investments | -73 | -73 | -77 | -1,438 | -119 | -61 | Upgrade |
Proceeds from Sale of Investments | 585 | 555 | 55 | 1,530 | 98 | 1,525 | Upgrade |
Payments for Business Acquisitions | -3,265 | -20,517 | -1,223 | -794 | -1,902 | -39,610 | Upgrade |
Other Investing Activities | 249 | 189 | 13 | 774 | 366 | 1,387 | Upgrade |
Investing Cash Flow | -12,046 | -20,820 | -2,009 | -623 | -2,344 | -37,557 | Upgrade |
Short-Term Debt Issued | - | 5,008 | - | - | - | - | Upgrade |
Short-Term Debt Repaid | - | -5,008 | - | - | - | - | Upgrade |
Long-Term Debt Issued | - | 16,963 | - | 2,000 | 1,000 | 3,000 | Upgrade |
Long-Term Debt Repaid | -12,945 | -9,613 | -4,149 | -14,433 | -9,414 | -5,683 | Upgrade |
Net Long-Term Debt Issued (Repaid) | -12,945 | 7,350 | -4,149 | -12,433 | -8,414 | -2,683 | Upgrade |
Issuance of Common Stock | 138 | 214 | 180 | 262 | 244 | 209 | Upgrade |
Repurchase of Common Stock | -1,348 | -1,708 | -1,972 | -1,487 | -934 | -978 | Upgrade |
Net Common Stock Issued (Repurchased) | -1,210 | -1,494 | -1,792 | -1,225 | -690 | -769 | Upgrade |
Common Dividends Paid | -11,338 | -11,025 | -10,539 | -10,043 | -9,261 | -7,716 | Upgrade |
Other Financing Activities | 65 | -42 | -742 | -1,102 | -674 | -333 | Upgrade |
Financing Cash Flow | -13,901 | -5,211 | -17,222 | -24,803 | -19,039 | -11,501 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 1 | -65 | 5 | -62 | -97 | -5 | Upgrade |
Net Cash Flow | -6,663 | -7,290 | 3,613 | -545 | 1,297 | -31,475 | Upgrade |
Beginning Cash & Cash Equivalents | 13,130 | 12,814 | 9,201 | 9,746 | 8,449 | 39,924 | Upgrade |
Ending Cash & Cash Equivalents | 6,467 | 5,524 | 12,814 | 9,201 | 9,746 | 8,449 | Upgrade |
Free Cash Flow | 18,239 | 17,832 | 22,062 | 24,248 | 21,990 | 16,790 | Upgrade |
Free Cash Flow Growth | 2.28% | -19.17% | -9.01% | 10.27% | 30.97% | 31.46% | Upgrade |
FCF Margin | 31.27% | 31.65% | 40.62% | 41.77% | 39.13% | 36.66% | Upgrade |
Free Cash Flow Per Share | 10.29 | 10.06 | 12.44 | 13.64 | 12.37 | 10.04 | Upgrade |
Levered Free Cash Flow | -3,980 | 16,051 | 11,382 | 8,536 | 10,952 | 8,641 | Upgrade |
Unlevered Free Cash Flow | 18,852 | 14,962 | 20,614 | 25,056 | 23,761 | 22,164 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.